Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: Role on chromatin remodeling at the PGC-1-alpha promoter

Human Molecular Genetics

Volumn 20, Issue 12, 2011, Pages 2422-2434

  Martin, Elodie ^a   Betuing, Sandrine ^a,b   Pagès, Christiane ^a   Cambon, Karine ^c,d   Auregan, Gwenaelle ^c,d   Deglon, Nicole ^c,d   Roze, Emmanuel ^a,e   Caboche, Jocelyne ^a  

^a Université Pierre et Marie Curie   (France)

^b UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^c DIF   (France)

^d Molecular Imaging Research Center   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOPROTEIN DARPP 32; PROTEIN KINASE; PROTEIN MSK 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ANALYSIS; HUNTINGTON CHOREA; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

MUS; RATTUS;

EID: 79957509694     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr148     Document Type: Article

References (67)

1. Roze, E., Bonnet, C., Betuing, S. and Caboche, J. (2010) Huntington's disease. Adv. Exp. Med. Biol., 685, 45-63.
2. Roze, E., Saudou, F. and Caboche, J. (2008) Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr. Opin. Neurol., 21, 497-503.
3. Cha, J.H. (2007) Transcriptional signatures in Huntington's disease. Prog. Neurobiol., 83, 228-248.
4. Luthi-Carter, R., Hanson, S.A., Strand, A.D., Bergstrom, D.A., Chun, W., Peters, N.L., Woods, A.M., Chan, E.Y., Kooperberg, C., Krainc, D. et al. (2002) Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. Hum. Mol. Genet., 11, 1911-1926.
5. Luthi-Carter, R., Strand, A., Peters, N.L., Solano, S.M., Hollingsworth, Z.R., Menon, A.S., Frey, A.S., Spektor, B.S., Penney, E.B., Schilling, G. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet., 9, 1259-1271.
6. Kuhn, A., Goldstein, D.R., Hodges, A., Strand, A.D., Sengstag, T., Kooperberg, C., Becanovic, K., Pouladi, M.A., Sathasivam, K., Cha, J.H. et al. (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet., 16, 1845-1861.
7. Anderson, A.N., Roncaroli, F., Hodges, A., Deprez, M. and Turkheimer, F.E. (2008) Chromosomal profiles of gene expression in Huntington's disease. Brain, 131, 381-388.
8. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M. and Spiegelman, B.M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92, 829-839.
9. Puigserver, P. and Spiegelman, B.M. (2003) Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator andmetabolic regulator. Endocr. Rev., 24, 78-90.
10. Cui, L., Jeong, H., Borovecki, F., Parkhurst, C.N., Tanese, N. and Krainc, D. (2006) Transcriptional repression of PGC-1alpha bymutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127, 59-69.
11. Weydt, P., Pineda, V.V., Torrence, A.E., Libby, R.T., Satterfield, T.F., Lazarowski, E.R., Gilbert, M.L., Morton, G.J., Bammler, T.K., Strand, A.D. et al. (2006) Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab., 4, 349-362.
12. Leone, T.C., Lehman, J.J., Finck, B.N., Schaeffer, P.J., Wende, A.R., Boudina, S., Courtois, M., Wozniak, D.F., Sambandam, N., Bernal-Mizrachi, C. et al. (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol., 3, e101.
13. Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.Y., Mootha, V.K., Jager, S., Vianna, C.R., Reznick, R.M. et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119, 121-135.
14. Chaturvedi, R.K., Adhihetty, P., Shukla, S., Hennessy, T., Calingasan, N., Yang, L., Starkov, A., Kiaei, M., Cannella, M., Sassone, J. et al. (2009) Impaired PGC-1alpha function in muscle in Huntington's disease. Hum. Mol. Genet., 18, 3048-3065.
15. Taherzadeh-Fard, E., Saft, C., Andrich, J., Wieczorek, S. and Arning, L. (2009) PGC-1alpha as modifier of onset age in Huntington disease. Mol. Neurodegener., 4, 10.
16. Cheung, P., Allis, C.D. and Sassone-Corsi, P. (2000) Signaling to chromatin through histone modifications. Cell, 103, 263-271.
17. Strahl, B.D. and Allis, C.D. (2000) The language of covalent histone modifications. Nature, 403, 41-45.
18. Liu, Y., Xu, X., Singh-Rodriguez, S., Zhao, Y. and Kuo, M.H. (2005) Histone H3 Ser10 phosphorylation-independent function of Snf1 and Reg1 proteins rescues a gcn5- mutant in HIS3 expression. Mol. Cell. Biol., 25, 10566-10579.
19. Berger, S.L. (2007) The complex language of chromatin regulation during transcription. Nature, 447, 407-412.
20. Nowak, S.J. and Corces, V.G. (2004) Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet., 20, 214-220.
21. Crosio, C., Cermakian, N., Allis, C.D. and Sassone-Corsi, P. (2000) Light induces chromatin modification in cells of the mammalian circadian clock. Nat. Neurosci., 3, 1241-1247.
22. Crosio, C., Heitz, E., Allis, C.D., Borrelli, E. and Sassone-Corsi, P. (2003) Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J. Cell Sci., 116, 4905-4914.
23. Soloaga, A., Thomson, S., Wiggin, G.R., Rampersaud, N., Dyson, M.H., Hazzalin, C.A., Mahadevan, L.C. and Arthur, J.S. (2003) MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J., 22, 2788-2797.
24. Hardingham, G.E., Fukunaga, Y. and Bading, H. (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci., 5, 405-414.
25. Maher, P., Dargusch, R., Bodai, L., Gerard, P.E., Purcell, J.M. and Marsh, J.L. (2011) ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum. Mol. Genet., 20, 261-270.
26. Brami-Cherrier, K., Valjent, E., Herve, D., Darragh, J., Corvol, J.C., Pages, C., Arthur, S.J., Girault, J.A. and Caboche, J. (2005) Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J. Neurosci., 25, 11444-11454.
27. Putignano, E., Lonetti, G., Cancedda, L., Ratto, G., Costa, M., Maffei, L. and Pizzorusso, T. (2007) Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. Neuron, 53, 747-759.
28. Tsankova, N.M., Kumar, A. and Nestler, E.J. (2004) Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J. Neurosci., 24, 5603-5610.
29. Sng, J.C., Taniura, H. and Yoneda, Y. (2006) Histone modifications in kainate-induced status epilepticus. Eur. J. Neurosci., 23, 1269-1282.
30. Huang, Y., Doherty, J.J. and Dingledine, R. (2002) Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J. Neurosci., 22, 8422-8428.
31. Deak, M., Clifton, A.D., Lucocq, L.M. and Alessi, D.R. (1998) Mitogenand stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J., 17, 4426-4441.
32. Arthur, J.S. and Cohen, P. (2000) MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett., 482, 44-48.
33. Wiggin, G.R., Soloaga, A., Foster, J.M., Murray-Tait, V., Cohen, P. and Arthur, J.S. (2002) MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell Biol., 22, 2871-2881.
34. Roze, E., Betuing, S., Deyts, C., Marcon, E., Brami-Cherrier, K., Pages, C., Humbert, S., Merienne, K. and Caboche, J. (2008) Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death. FASEB J., 22, 1083-1093.
35. de Almeida, L.P., Ross, C.A., Zala, D., Aebischer, P. and Deglon, N. (2002) Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J. Neurosci., 22, 3473-3483.
36. Regulier, E., Trottier, Y., Perrin, V., Aebischer, P. and Deglon, N. (2003) Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. Hum. Mol. Genet., 12, 2827-2836.
37. Svenningsson, P., Nishi, A., Fisone, G., Girault, J.A., Nairn, A.C. and Greengard, P. (2004) DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol., 44, 269-296.
38. Bibb, J.A., Yan, Z., Svenningsson, P., Snyder, G.L., Pieribone, V.A., Horiuchi, A., Nairn, A.C., Messer, A. and Greengard, P. (2000) Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc. Natl Acad. Sci. USA, 97, 6809-6814.
39. Canals, J.M., Pineda, J.R., Torres-Peraza, J.F., Bosch, M., Martin-Ibanez, R., Munoz, M.T., Mengod, G., Ernfors, P. and Alberch, J. (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci., 24, 7727-7739.
40. Diguet, E., Petit, F., Escartin, C., Cambon, K., Bizat, N., Dufour, N., Hantraye, P., Deglon, N. and Brouillet, E. (2009) Normal aging modulates the neurotoxicity of mutant huntingtin. PLoS ONE, 4, e4637.
41. Brami-Cherrier, K., Roze, E., Girault, J.A., Betuing, S. and Caboche, J. (2009) Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J. Neurochem., 108, 1323-1335.
42. Gonzalez, G.A. and Montminy, M.R. (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell, 59, 675-680.
43. Brami-Cherrier, K., Lavaur, J., Pages, C., Arthur, J.S. and Caboche, J. (2007) Glutamate induces histone H3 phosphorylation but not acetylation in striatal neurons: role of mitogen- and stress-activated kinase-1. J. Neurochem., 101, 697-708.
44. Handschin, C., Rhee, J., Lin, J., Tarr, P.T. and Spiegelman, B.M. (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc. Natl Acad. Sci. USA, 100, 7111-7116.
45. Beal, M.F., Brouillet, E., Jenkins, B.G., Ferrante, R.J., Kowall, N.W., Miller, J.M., Storey, E., Srivastava, R., Rosen, B.R. and Hyman, B.T. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci., 13, 4181-4192.
46. De March, Z., Zuccato, C., Giampa, C., Patassini, S., Bari, M., Gasperi, V., De Ceballos, M.L., Bernardi, G., Maccarrone, M., Cattaneo, E. et al. (2008) Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions. Neuroscience, 152, 734-740.
47. Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., MacDonald, M.E., Lessmann, V., Humbert, S. et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell, 118, 127-138.
48. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P. et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 127, 1109-1122.
49. Zong, H., Ren, J.M., Young, L.H., Pypaert, M., Mu, J., Birnbaum, M.J. and Shulman, G.I. (2002) AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl Acad. Sci. USA, 99, 15983-15987.
50. Jager, S., Handschin, C., St-Pierre, J. and Spiegelman, B.M. (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl Acad. Sci. USA, 104, 12017-12022.
51. Outeiro, T.F., Marques, O. and Kazantsev, A. (2008) Therapeutic role of sirtuins in neurodegenerative disease. Biochim. Biophys. Acta, 1782, 363-369.
52. Ho, D.J., Calingasan, N.Y., Wille, E., Dumont, M. and Beal, M.F. (2010) Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Exp. Neurol., 225, 74-84.
53. Wareski, P., Vaarmann, A., Choubey, V., Safiulina, D., Liiv, J., Kuum, M. and Kaasik, A. (2009) PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons. J. Biol. Chem., 284, 21379-21385.
54. Herzig, S., Long, F., Jhala, U.S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P. et al. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature, 413, 179-183.
55. Wu, Z., Huang, X., Feng, Y., Handschin, C., Gullicksen, P.S., Bare, O., Labow, M., Spiegelman, B. and Stevenson, S.C. (2006) Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc. Natl Acad. Sci. USA, 103, 14379-14384.
56. Gutsaeva, D.R., Carraway, M.S., Suliman, H.B., Demchenko, I.T., Shitara, H., Yonekawa, H. and Piantadosi, C.A. (2008) Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. J. Neurosci., 28, 2015-2024.
57. Okamoto, S., Pouladi, M.A., Talantova, M., Yao, D., Xia, P., Ehrnhoefer, D.E., Zaidi, R., Clemente, A., Kaul, M., Graham, R.K. et al. (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med., 15, 1407-1413.
58. McConoughey, S.J., Basso, M., Niatsetskaya, Z.V., Sleiman, S.F., Smirnova, N.A., Langley, B.C., Mahishi, L., Cooper, A.J., Antonyak, M.A., Cerione, R.A. et al. (2010) Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol. Med., 2, 349-370.
59. Karpuj, M.V., Garren, H., Slunt, H., Price, D.L., Gusella, J., Becher, M.W. and Steinman, L. (1999) Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc. Natl Acad. Sci. USA, 96, 7388-7393.
60. Lesort, M., Tucholski, J., Zhang, J. and Johnson, G.V. (2000) Impaired mitochondrial function results in increased tissue transglutaminase activity in situ. J. Neurochem., 75, 1951-1961.
61. Stack, E.C., Kubilus, J.K., Smith, K., Cormier, K., Del Signore, S.J., Guelin, E., Ryu, H., Hersch, S.M. and Ferrante, R.J. (2005) Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J. Comp. Neurol., 490, 354-370.
62. Mantamadiotis, T., Lemberger, T., Bleckmann, S.C., Kern, H., Kretz, O., Martin Villalba, A., Tronche, F., Kellendonk, C., Gau, D., Kapfhammer, J. et al. (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat. Genet., 31, 47-54.
63. Brouillet, E., Conde, F., Beal, M.F. and Hantraye, P. (1999) Replicating Huntington's disease phenotype in experimental animals. Prog. Neurobiol., 59, 427-468.
64. Deglon, N., Tseng, J.L., Bensadoun, J.C., Zurn, A.D., Arsenijevic, Y., Pereira de Almeida, L., Zufferey, R., Trono, D. and Aebischer, P. (2000) Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther., 11, 179-190.
65. Hottinger, A.F., Azzouz, M., Deglon, N., Aebischer, P. and Zurn, A.D. (2000) Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus. J. Neurosci., 20, 5587-5593.
66. Huang, Q.Y., Yu, L., Ferrante, R.J. and Chen, J.F. (2007) Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice. Neurosci. Lett., 418, 175-180.
67. Choi, Y.S., Lee, B., Cho, H.Y., Reyes, I.B., Pu, X.A., Saido, T.C., Hoyt, K.R. and Obrietan, K. (2009) CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease. Neurobiol. Dis., 36, 259-268.